Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)
Abstract Background Pancreatic cancer is susceptible to gemcitabine resistance, and patients receive less benefit from gemcitabine chemotherapy. Previous studies report that gambogic acid possesses antineoplastic properties; however, to our knowledge, there have been no specific studies on its effec...
Sparad:
| Huvudupphov: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2017-08-01
|
| Serie: | Journal of Experimental & Clinical Cancer Research |
| Ämnen: | |
| Länkar: | http://link.springer.com/article/10.1186/s13046-017-0579-0 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|